Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results

Go back to Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
(NASDAQ: FULC) Delayed: 3.73 -0.01 (0.27%)
Previous Close $3.74    52 Week High $ 
Open $3.75    52 Week Low $ 
Day High $3.76    P/E N/A 
Day Low $3.71    EPS $ 
Volume 533,159